Table TDI-19. New and all clients entering outpatient treatment: distribution by primary drug at treatment in 2004 for those countries supplying data – Part (i) New clients

Country

Opioids

Cocaine

Stimulants

Hypnotics, sedatives

Hallucinogens

Volatile inhalants

Cannabis

Other substances

Base
(known status)

Status unknown

Czech Republic

20.6

0.2

43.1

1.3

0.7

3.1

30.4

0.6

1056

5

Denmark

22.7

8.1

15.6

2.0

0.0

0.0

47.9

3.6

1143

158

Germany

23.1

6.8

9.4

2.0

0.4

0.1

56.4

1.8

13204

0

Greece

78.9

3.1

0.7

1.1

0.1

0.2

15.8

0.2

1221

0

Italy

52.9

16.5

1.0

0.5

0.1

0.6

23.8

4.8

24768

9540

Cyprus

54.3

9.1

2.4

0.0

0.6

0.0

33.5

0.0

164

1

Hungary

6.8

0.8

10.4

9.0

0.4

0.8

60.8

11.0

4398

1

Malta

81.6

11.6

5.4

0.7

0.0

0.0

0.7

0.0

147

20

Netherlands

11.1

36.6

8.3

3.1

1.4

0.1

38.2

1.2

4785

0

Slovenia

77.9

1.0

1.2

0.6

0.0

0.0

19.4

0.0

521

0

Slovakia

23.2

0.7

29.1

9.5

1.3

13.7

21.6

1.0

306

0

Finland

16.6

0.0

30.2

3.6

0.2

0.4

48.1

0.9

447

0

Sweden

21.2

4.5

22.2

14.2

0.2

0.5

35.0

2.2

829

0

United Kingdom

56.7

11.8

7.0

2.3

0.1

0.8

19.1

2.2

26990

899

Bulgaria

88.5

0.0

1.8

0.5

0.0

0.5

8.8

0.0

442

0

 

 

 

 

 

 

 

 

 

 

 

Total

43.6

12.7

6.6

2.2

0.2

0.6

30.9

3.3

80421

10624

Notes:

See 'General notes for interpreting data' on the Explanatory notes and help page.

Source:

2005 Reitox national reports - TDI outpatient treatment centres

Data filter | tditab19a-en.xml